Autoantibody Biomarkers in Rheumatic Diseases

Autoantibodies encountered in patients with systemic rheumatic diseases bear clinical significance as a biomarker to help or predict diagnosis, clinical phenotypes, prognosis, and treatment decision-making. Furthermore, evidence has accumulated regarding the active involvement of disease-specific or...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Eun Ha, Ha, You-Jung, Lee, Yun Jong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073052/
https://www.ncbi.nlm.nih.gov/pubmed/32085664
http://dx.doi.org/10.3390/ijms21041382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073052/
https://www.ncbi.nlm.nih.gov/pubmed/32085664
http://dx.doi.org/10.3390/ijms21041382

Ejemplares similares